{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:21:34Z","timestamp":1773051694418,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ejpn.2022.10.002","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T08:50:06Z","timestamp":1665996606000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Thalassemia and Moyamoya Syndrome: Epidemiology and long-term outcome"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9075-2000","authenticated-orcid":false,"given":"Shambaditya","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biman Kanti","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alak","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8192-0807","authenticated-orcid":false,"given":"Ritwik","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arka Prava","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1733-3429","authenticated-orcid":false,"given":"Souvik","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejpn.2022.10.002_bib1","article-title":"The disease presentation of Moyamoya angiopathy in Eastern India","volume":"29","author":"Das","year":"2020","journal-title":"J.\u00a0Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.ejpn.2022.10.002_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.837704","article-title":"Epidemiology of moyamoya angiopathy in Eastern India","author":"Das","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejpn.2022.10.002_bib3","article-title":"Thalassemia and Moyamoya syndrome: unfurling an intriguing association","author":"Das","year":"2019","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.ejpn.2022.10.002_bib4","series-title":"Acute Stroke in Young Adult Secondary to Moyamoya Angiopathy Unveiling HbE-\u03b2 Thalassemia","author":"Das","year":"2021"},{"key":"10.1016\/j.ejpn.2022.10.002_bib5","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","author":"Scott","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejpn.2022.10.002_bib6","article-title":"Moyamoya disease and beta-thalassemia","author":"Mukherjee","year":"1995","journal-title":"J.\u00a0Assoc. Phys. India"},{"key":"10.1016\/j.ejpn.2022.10.002_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2013.05.005","article-title":"A\u00a0rare case of Moyamoya syndrome in a \u03b2-thalassemia major patient","author":"Inati","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ejpn.2022.10.002_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocn.2009.10.023","article-title":"Beta-thalassemia intermedia associated with moyamoya syndrome","author":"G\u00f6ksel","year":"2010","journal-title":"J.\u00a0Clin. Neurosci."},{"key":"10.1016\/j.ejpn.2022.10.002_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/08830738060210010501","article-title":"Moyamoya syndrome in a splenectomized patient with \u03b2-thalassemia intermedia","author":"Sanefuji","year":"2006","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ejpn.2022.10.002_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/MPH.0b013e3181ed0e84","article-title":"Stroke in a young boy with \u03b2-thalassemia intermedia secondary to moyamoya syndrome","author":"Oberoi","year":"2010","journal-title":"J.\u00a0Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ejpn.2022.10.002_bib11","article-title":"Moyamoya syndrome in a child with \u03b2-thalassemia major","author":"Roy","year":"2020","journal-title":"J.\u00a0Pediatr. Neurol."},{"key":"10.1016\/j.ejpn.2022.10.002_bib12","article-title":"HbE-Beta thalassemia with moyamoya syndrome: a rare association","author":"Agrawal","year":"2019","journal-title":"Indian J Pediatr 2019 876"},{"key":"10.1016\/j.ejpn.2022.10.002_bib13","first-page":"345","article-title":"Case report vasculopathy in beta thalessemia intermedia : a rare case report","volume":"2","author":"Nadkarni","year":"2014","journal-title":"Scholars J. Appl. Med. Sci."},{"key":"10.1016\/j.ejpn.2022.10.002_bib14","doi-asserted-by":"crossref","DOI":"10.4103\/jpgm.JPGM_468_17","article-title":"Moyamoya syndrome in hemoglobin E-beta thalassemia: a rare presentation and association","author":"Doctor","year":"2018","journal-title":"J.\u00a0Postgrad. Med."},{"key":"10.1016\/j.ejpn.2022.10.002_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.pediatrneurol.2007.09.011","article-title":"Moyamoya disease associated with hemoglobin Fairfax and beta-thalassemia","author":"Marden","year":"2008","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ejpn.2022.10.002_bib16","doi-asserted-by":"crossref","DOI":"10.15274\/NRJ-2014-10003","article-title":"Ivy sign in mildly symptomatic \u03b2-thalassemia intermedia, with development of moyamoya disease","author":"El Beltagi","year":"2014","journal-title":"NeuroRadiol. J."},{"key":"10.1016\/j.ejpn.2022.10.002_bib17","article-title":"Journal of pediatric critical care","author":"Gupta","year":"2017","journal-title":"J.\u00a0Pediatr Crit CARE"},{"key":"10.1016\/j.ejpn.2022.10.002_bib18","doi-asserted-by":"crossref","DOI":"10.3109\/08880018.2011.583976","article-title":"Cerebral infarction in the setting of moyamoya in a pediatric patient with sickle \u03b2\u00a0+ -thalassemia","author":"Ray","year":"2011","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ejpn.2022.10.002_bib19","series-title":"Moya Moya Syndrome in a HbE Beta Thalassemic Child Presenting with Hemiplegia in Rural West Bengal","author":"Nath Sarkar","year":"2016"},{"key":"10.1016\/j.ejpn.2022.10.002_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.21850","article-title":"A\u00a0case of moyamoya syndrome and hemoglobin E\/beta-thalassemia","author":"Parker","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ejpn.2022.10.002_bib21","doi-asserted-by":"crossref","DOI":"10.1159\/000381331","article-title":"Another rare unstable hemoglobinopathy: hemoglobin casper\/southampton associated with moyamoya disease","author":"Haque","year":"2015","journal-title":"Cerebrovasc Dis Extra"},{"key":"10.1016\/j.ejpn.2022.10.002_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104036","article-title":"Multiple sclerosis and Moyamoya angiopathy: Mimic and misdiagnosis","volume":"66","author":"Das","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.ejpn.2022.10.002_bib23","article-title":"Spicy foods triggering clinical symptoms in Moyamoya angiopathy","author":"Dubey","year":"2020","journal-title":"J.\u00a0Neurosurg. Sci."},{"key":"10.1016\/j.ejpn.2022.10.002_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106783","article-title":"Limb-shaking TIA in moyamoya angiopathy","author":"Das","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.ejpn.2022.10.002_bib25","article-title":"Temporal lobe epilepsy with nocturnal wandering leading to discovery of Moyamoya Angiopathy","author":"Das","year":"2021","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.ejpn.2022.10.002_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106432","article-title":"Asymptomatic\u201d moyamoya angiopathy: is it truly asymptomatic?","author":"Das","year":"2022","journal-title":"J.\u00a0Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.ejpn.2022.10.002_bib27","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2019001142","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults","author":"DeBaun","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.ejpn.2022.10.002_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/j.1468-1331.2011.03431.x","article-title":"Etiology and treatment of ischaemic stroke in patients with \u03b2-thalassemia major","author":"Vassilopoulou","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"SUPPL.1","key":"10.1016\/j.ejpn.2022.10.002_bib29","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S0268-960X(12)70007-3","article-title":"Hypercoagulability in non-transfusion-dependent thalassemia","volume":"26","author":"Cappellini","year":"2012","journal-title":"Blood Rev."},{"key":"10.1016\/j.ejpn.2022.10.002_bib30","doi-asserted-by":"crossref","DOI":"10.1159\/000040814","article-title":"Thromboembolic events in beta thalassemia major: an Italian multicenter study","author":"Borgna Pignatti","year":"1998","journal-title":"Acta Haematol."},{"key":"10.1016\/j.ejpn.2022.10.002_bib31","volume":"vol. 96","author":"Taher","year":"2006"},{"key":"10.1016\/j.ejpn.2022.10.002_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.20938","article-title":"Cerebrovascular accident in \u03b2-thalassemia major (\u03b2-TM) and \u03b2-thalassemia intermedia (\u03b2-TI)","author":"Karimi","year":"2008","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejpn.2022.10.002_bib33","article-title":"Magnetic resonance imaging to determine the incidence of brain ischaemia in patients with \u03b2-thalassaemia intermedia","author":"Karimi","year":"2010","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.ejpn.2022.10.002_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/j.1538-7836.2010.03940.x","article-title":"Splenectomy and thrombosis: the case of thalassemia intermedia","author":"Taher","year":"2010","journal-title":"J.\u00a0Thromb. Haemostasis"},{"key":"10.1016\/j.ejpn.2022.10.002_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.2830440114","article-title":"Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes","author":"Yashar","year":"1993","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejpn.2022.10.002_bib36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2141.2000.02376.x","article-title":"Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia","volume":"111","author":"Lrbbrcgfam","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejpn.2022.10.002_bib37","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.thromres.2007.02.006","article-title":"Hemostatic alterations in splenectomized and non-splenectomized patients with beta-thalassemia\/hemoglobin E disease","volume":"120","author":"Tripatara Ajjtkk","year":"2007","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejpn.2022.10.002_bib38","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1160\/TH08-03-0157","article-title":"Increased platelet adhesion under flow conditions is induced by both thalassemic platelets and red blood cells","volume":"100","year":"2008","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.ejpn.2022.10.002_bib39","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/j.1538-7836.2010.04030.x","article-title":"Red cells playing as activated platelets in thalassemia intermedia","volume":"8","author":"Mannucci","year":"2010","journal-title":"J.\u00a0Thromb. Haemostasis"},{"key":"10.1016\/j.ejpn.2022.10.002_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2141.1997.1502965.x","article-title":"In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major","volume":"98","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejpn.2022.10.002_bib41","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","article-title":"Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study","volume":"115","author":"At Taher Kmmkae-Bkbsd","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejpn.2022.10.002_bib42","article-title":"Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1","volume":"13","author":"Santoro Tgmkatjsmc","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpn.2022.10.002_bib43","doi-asserted-by":"crossref","DOI":"10.1017\/cjn.2020.117","article-title":"COVID-19 presenting with thalamic hemorrhage unmasking moyamoya angiopathy","volume":"47","author":"Ghosh","year":"2020","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.ejpn.2022.10.002_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-239307","article-title":"Moyamoya angiopathy unmasking systemic lupus erythematosus","author":"Das","year":"2021","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.ejpn.2022.10.002_bib45","article-title":"Impact of COVID-19 pandemic in natural course of Moyamoya Angiopathy: an experience from tertiary-care-center in India","volume":"571","author":"Das","year":"2021","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"10.1016\/j.ejpn.2022.10.002_bib46","article-title":"Decreased nitrite reductase activity of deoxyhemoglobin correlates with platelet activation in hemoglobin E\/\u00df-thalassemia subjects","volume":"13","author":"Chamchoi Sskptspskp","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpn.2022.10.002_bib47","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1089\/ars.2016.6806","article-title":"HbE\/\u03b2-thalassemia and oxidative stress: the key to pathophysiological mechanisms and novel therapeutics","volume":"26","year":"2017","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejpn.2022.10.002_bib48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.wneu.2020.01.182","article-title":"Cerebral revascularization for moyamoya syndrome associated with sickle cell disease: a systematic review of the literature on the role of Extracranial-intracranial bypass in treating neurologic manifestations of pediatric patients with sickle cell disease","volume":"137","author":"Terrell","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ejpn.2022.10.002_bib49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.wneu.2019.11.137","article-title":"Outcomes in patients with moyamoya syndrome and sickle cell disease: a systematic review","volume":"135","author":"Newman","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ejpn.2022.10.002_bib50","doi-asserted-by":"crossref","DOI":"10.1007\/s00277-019-03765-0","article-title":"Frequency of silent brain lesions and aspirin protection evaluation over 3 years follow-up in beta thalassemia patients","author":"Karimi","year":"2019","journal-title":"Ann. Hematol."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109037982200143X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109037982200143X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:40:04Z","timestamp":1761072004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109037982200143X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":50,"alternative-id":["S109037982200143X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2022.10.002","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thalassemia and Moyamoya Syndrome: Epidemiology and long-term outcome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2022.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}